SPOTLIGHT -
Dr Miller is Medical Director, Brain Health, Exeter, New Hampshire; Editor in Chief, Psychiatric Times; Staff Psychiatrist, Seacoast Mental Health Center, Exeter; and Consulting Psychiatrist, Insight Meditation Society, Barre, Massachusetts.
Pharmacogenomics: Sticking to the Evidence Base
Pharmacogenomics at the 2024 APA Annual Meeting.
Bias in Record Keeping: A Real Life Example
Biases can be apparent in case notes. Psychiatric Times Editor-in-Chief sat down with us at the 2024 APA Annual Meeting to share more.
Long-Acting Injectable vs Oral Antipsychotics: Part 2 of a Conversation With Peter J. Weiden, MD
Peter J. Weiden, MD, sat down with Psychiatric Times’ Editor-in-Chief at the 2024 Annual Meeting. Here’s Part 2 of their conversation.
Long-Acting Injectables: Part 1 of a Conversation With Peter J. Weiden, MD
Peter J. Weiden, MD, sat down with Psychiatric Times’ Editor-in-Chief at the 2024 Annual Meeting. Here’s Part 1 of their conversation.
Lithium Undervalued? A Conversation With Jonathan M. Meyer, MD
Jonathan M. Meyer, MD, sat down with Psychiatric Times' Editor-in-Chief at the 2024 APA Annual Meeting.
An Artisanal Approach to Care: A Conversation with Joseph F. Goldberg, MD
Joseph F. Goldberg, MD, sat down with Psychiatric Times' Editor-in-Chief at the 2024 APA Annual Meeting.
Suicide
Suicide is a word that conjures a wide range of intense emotions.
Exploring the STAR*D Controversy
STAR*D trial is one of the most important foundational studies in psychiatry to guide the treatment of unipolar major depression. Get ready to explore a dialogue between the original STAR*D authors and a group of authors who call STAR*D into question.
Mass Shootings’ Relationship to Mental Illness
If all violence in the US that is due to mental disorders could be eliminated, 95% to 97% of violent behavior would remain.
Medication Pipeline: Antidepressants and ADHD Rx
Check out this broad range of innovative medications in development with the goal of providing psychiatric clinicians with novel treatments in the quest to decrease patient suffering and improve function and quality of life.
Medication Pipeline: Schizophrenia and PTSD
Here's an update on which medications are on the horizon for the treatment of schizophrenia and PTSD.
STAR*D Dethroned?
Since 2006, STAR*D stands out as an icon guiding treatment decisions of major depressive disorder. But what if it is broken?
Gabapentinoids: A Deeper Look
"During the past 5 years has gabapentin retained its position as one of the top 10 drugs prescribed in the United States."
Deep Dive on Dementia at the 2023 Psychiatric Times World CME Conference
Don't miss the the 2023 Psychiatric Times World CME conference, where our Editor in Chief will present on the 14 different types of dementia!
Updates on Schizophrenia at the 2023 Psychiatric Times World CME Conference
Don't miss updates on schizophrenia at our conference, beginning at 3:10PM EST!
Why You Should Attend the 2023 Psychiatric Times World CME Conference
Our Editor in Chief explains why you should attend our conference!
You Have to Say Hello Before You Can Say Goodbye
Residues of past traumatic events can deeply impact our present experiences and our functioning in ways that we are not aware of consciously. We must process and let go of these experiences in order to heal.
Keeping Up With the Times
Have you registered for the 2023 Annual Psychiatric Times World CME Conference?
A Menagerie of Unfortunate Events
"No matter where you are in your career, it is our generation of providers who have the opportunity to facilitate how the medicine of today evolves into the medicine of tomorrow."
Dementia Treatment: An Unmet Need
"There is clearly a large unmet need not only to improve our treatment of AD, but to provide treatment options for all the dementias."
Continued Cannabis Confusion
Should cannabis be regulated in the United States in a manner similar to alcohol and tobacco?
Evolution of Pharmacological Treatments at the 2023 APA Annual Meeting
An inside look at what treatments are being discussed in San Francisco...
Teach and Treat Your Children Well
"It is essential to have an aggressive path forward to increase public awareness of mental health and illness, education on early intervention and treatment access, and continued destigmatization of mental illness."
Yes, It’s All in Your Head
Patients' symptoms often have an etiology that is actually "all in their head..."
The Clock-Drawing Test
A look at one of the most informative yet easy-to-administer tests for assessing brain dysfunction.
Treatment Resistant: Is It a Misnomer?
"The history of medicine is rich in blaming the disease or the patient for 'untreatable' symptoms, until we stumble upon or develop a treatment that is, in fact, effective."
Rx Evolution: An Ununified Model of MDD and Pharmacological Paradigms
Keep the Cart Behind the Horse: Privilege and Responsibility as a Provider
Remember to keep the cart behind the horse while practicing medicine.
Rx Evolution: Pharmacological Paradigms for the Treatment of Schizophrenia
We remain challenged to improve treatments and outcomes in schizophrenia. Explore the latest options.
Reflections on Christmases Past
What is most memorable about your childhood holiday celebrations?